Clinical Updates

If you’re suffering from a cold, Motrin, Aleve and similar drugs can help you feel better, the authors of the… »   

An experimental antibody treatment helped rabbits and monkeys survive a deadly dose of anthrax bacteria and proved safe in humans,… »   

Avastin, a widely used cancer drug, shrank tumors growing along the nerves leading to the ears, improving the hearing… »   

GlaxoSmithKline’s cervical cancer vaccine Cervarix has won a green light from the World Health Organisation (WHO) for use in developing… »   

Recent industry deals to accept lower costs for the Medicare health program are a first step in healthcare reform but… »   

Data Published in the New England Journal of Medicine Support Use of Raxibacumab (ABthrax (TM)) for the Treatment of Inhalation… »   

Transplant patients rely on drugs to prevent graft rejection, but at the cost of serious side effects. The class of… »   

The Justice Department argued on Monday that drug company payments to prevent generic competition were “presumptively unlawful,” a shift from… »   

EU regulators are probing some drug firms over suspected anti-competitive practices that include deals with makers of cheap generics to… »   

U.S. regulators on Tuesday ordered stronger warnings about overdoses with the painkilling drugs Darvon and Darvocet and rejected a… »   

As well as protecting against the two most common cervical cancer-causing viruses, the vaccine Cervarix also provides protection against the… »   

Biotechnology company Protalix BioTherapeutics Inc said on Monday it has been approached by the U.S. Food and Drug Administration… »   

An international food safety body has set rules to cut levels of cancer-causing chemicals and bacteria in various food items… »   

U.S. health advisers recommended Tuesday to lower the maximum dose of over-the-counter acetaminophen—the key ingredient in Tylenol, Excedrin and many… »   

Drugs shaped like Snoopy, Transformers and President Barack Obama’s head recently showed up on Kansas City area streets, adding to… »